AMT-151 in Patients With Selected Advanced Solid Tumours
NCT 05498597 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05498597 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 03175224 Brief Summary To assess: efficacy of APL-101 as monotherapy for…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06756932 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 04862663 Brief Summary A Phase Ib/III Open-label, Randomised Study of Capivasertib…
Read more arrow_forwardNCT 05523947 Brief Summary This first-in-human study will be counducted to evaluate…
Read more arrow_forwardNCT 05868174 Brief Summary This is an open label, single-arm, multicentre dose…
Read more arrow_forwardNCT 05756907 Brief Summary This is a Phase 1b/2a, open-label, adaptive-design…
Read more arrow_forward